Gabapentin is a prescription medication classified under neurology. It is available in pill form in strengths of 100 mg, 300 mg, 400 mg, 600 mg, and 800 mg. In Hong Kong, gabapentin is regulated by the Department of Health and is prescribed for specific neurologic conditions.
Gabapentin’s therapeutic effect comes from binding to the α2δ subunit of voltage-gated calcium channels in the central nervous system. This action decreases calcium influx into nerve terminals, which reduces the release of excitatory neurotransmitters such as glutamate, substance P, and norepinephrine. By dampening excessive neuronal firing, gabapentin helps control seizure activity and alleviates abnormal pain signaling that underlies neuropathic pain.
In Hong Kong, gabapentin is officially indicated for:
These indications are supported by regulatory approval and clinical guidelines. Gabapentin is generally prescribed when first-line agents are insufficient or not tolerated.
Research and clinical practice have explored additional uses of gabapentin, though these are not approved by Hong Kong health authorities:
Disclaimer: Off-label use requires careful medical supervision, individualized risk assessment, and informed consent.
If you have any of the above conditions, discuss alternative therapies with your healthcare provider.
These effects are often mild and may improve as the dose is stabilized.
If you experience rash, difficulty breathing, swelling of the face or throat, or suicidal ideation, seek emergency medical care.
General advice: Inform all prescribing professionals about any supplements, herbal products, or over-the-counter medications you are using.
Routine laboratory monitoring beyond renal function is generally not required for gabapentin.
This article provides educational information about gabapentin and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Evidence suggests gabapentin may have anxiolytic properties, but data are limited and it is not an approved anxiety treatment in Hong Kong. Off-label use should only occur under close medical supervision.
Severe dizziness can increase fall risk. Contact your prescriber promptly; they may adjust the dose, change the dosing schedule, or consider an alternative medication.
Weight gain is not a common side effect of gabapentin. Some patients report mild appetite changes, but any significant weight fluctuation should be discussed with a healthcare professional.
Rarely, patients may experience blurred vision or double vision. If visual disturbances occur, cease the medication and seek medical attention.
Both bind to the α2δ subunit of calcium channels, but pregabalin has higher potency and a shorter half-life. Dosing schedules, approved indications, and side-effect profiles also differ.
Yes, but keep the medication in its original labeled container, carry a copy of the prescription, and be aware of any country-specific import restrictions for controlled substances.
Concurrent use may increase sedation. Monitor for excessive drowsiness and discuss dosage timing with your provider.
Generic gabapentin tablets often bear imprints such as “GAB 100” or “GAB 300” depending on strength, but appearance can vary by manufacturer. Verify with your pharmacist.
Prescriptions are usually written for a 30-day supply, but refill intervals are determined by the prescriber based on clinical response and safety monitoring.